Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study

INTRODUCTION: Fibromyalgia is characterized by widespread and chronic pain, and its prevalence is increasing worldwide. Milnacipran, an antidepressant, is often prescribed for fibromyalgia with a possible beneficial effect on central pain modulation. The aim of this study was to evaluate if milnacip...

Descripción completa

Detalles Bibliográficos
Autores principales: Pickering, Gisèle, Macian, Nicolas, Delage, Noémie, Picard, Pascale, Cardot, Jean-Michel, Sickout-Arondo, Sophia, Giron, Fatiha, Dualé, Christian, Pereira, Bruno, Marcaillou, Fabienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089099/
https://www.ncbi.nlm.nih.gov/pubmed/30127596
http://dx.doi.org/10.2147/DDDT.S162810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089099/
https://www.ncbi.nlm.nih.gov/pubmed/30127596
http://dx.doi.org/10.2147/DDDT.S162810

Ejemplares similares